Jaideep
@jaideeppatelmd
Cardiologist @hopkinsheart | Director of #cvPrev @GBMCHealthcare | #SouthAsianCVD #SACHI | Torontonian🇨🇦 #theprideoflondon⚽️ | ℹ️🤍🏠🎵 | ☕️ with a view
ID:1075642928
https://www.linkedin.com/in/jaideep-patel-md-0a594a202 10-01-2013 04:24:01
5,6K Tweets
1,5K Followers
952 Following
Follow People
Atheroma microcalcification activity as quantified by 18F–NaF uptake (PET-CT) in individuals w/ subclinical atherosclerosis is significantly reduced after six months of high intensity statin therapy
🔗atherosclerosis-journal.com/article/S0021-…
João Borges Rosa Piotr Slomka PhD European Atherosclerosis Society #CvPrev
Excellent resource discussing strategies that are essential to mitigate disparities in CVD outcomes & optimizing CVD risk in women.
Congratulations Priyanka Satish Anandita Agarwala Kulkarni, MD FACC and thank you involving me!
Johns Hopkins Ciccarone Center Johns Hopkins Medicine Johns Hopkins Cardiology Garima Sharma M.D Roger Blumenthal
Evidence Builds to Support Colchicine in Treating Atherosclerotic Cardiovascular Disease medscape.com/viewarticle/ev… medscape.com/viewarticle/ev…
the time is now! Dr. Michael Garshick Brittany Weber Binita Shah
Quite the honor to prepare this editorial on racial/ethnic diff in Lp(a) testing [led by former The Osler Medical Residency 🌟 Ramzi Dudum] w experts JaredSpitzMD Harpreet Bhatia
Should Lp(a) be introduced into risk assessment models?
Sadiya Khan Kuni Matsushita Chiadi Ndumele Sam Tsimikas, MD
Understanding the spectrum of #CVrisk in women. A primer on
✅Traditional RF
✅ APOs & CV RF
✅ Sex specific risk
✅ Risk @ menopause and HRT
Thanks to editors Matthew Budoff MD Suvasini Lakshmanan and coauthors Anandita Agarwala Kulkarni, MD FACC Jaideep and Dr. Eleonora Avenatti
bit.ly/3WyVYTd